Upregulated SLC11A1 expression in CRC is associated with poor prognosis and advanced clinicopathological stages (pathological, T, and N stages), which indicates that SLC11A1 tends to be an unfavorable factor in CRC patients. This evidence concerns the gene SLC11A1 and colorectal carcinoma.